21 Hrs
المصدر:
The Washington Post
FDA studies for many products incomplete
The FDA allows companies to conduct postmarket studies to accelerate the approval process for drugs and devices. However, records indicate that many of these studies are frequently delayed or overdue.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading